Advanced search for publications

Enter your keywords

Cost Comparison Charts

Overview The charts included within this report are organised by BNF classification (legacy) and show comparative costs at the NHS basic price1,2 (as of April 2026) for selected agents. Except where indicated otherwise, each chart shows the cost of 1 year3 of treatment at a commonly prescribed daily dose (shown in brackets). The doses given […]

Price Concessionary Bulletin

The purpose of this bulletin is to present the predicted cost impact of drug price changes, both through the Price Concessions list and also monthly drug tariff (DT) cost variations. The data is calculated by matching the ePACT2 prescribing data for the latest month available to the current prices listed in the NHSBSA Drug Tariff […]

Medicines Value Calculators

Overview These calculators illustrate potential savings from selected changes in prescribing. Many of the examples shown involve relatively simple switches from one formulation to another, with no change in drug or total daily dose. Others show the savings that could be made from switching to effective alternatives from the same therapeutic class. Frequency Quarterly Data […]

Drug Tariff Monitor

The purpose of this report is to present the predicted cost impact of category A, M and C drug tariff PartVIIIA price changes on primary care spending. The data is calculated by matching the ePACT2 prescribing data for the latest month available to the current prices listed in the NHSBSA Drug Tariff PartVIIIA. An adjustment […]

Ciclosporin eye drops for dry eye disease

This document compares the ciclosporin eye drops licensed in the UK for use in adults. It is intended as a quick reference to summarise differences between the available preparations.

Comparison of DOACs for Atrial Fibrillation

Comparison tables are produced for prescribers and medicines management teams. They are designed to assist in prescribing and decision-making within a specific therapeutic area. Several direct oral anticoagulants (DOACs) are licensed for the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF). This comparison table allows prescribers and other healthcare […]

What are the statutory obligations of an ICS for the implementation of NICE guidance

The National Institute for Health and Clinical Excellence (NICE) produce a range of guidance types, some of which commissioners have a statutory obligation to implement. This document sets out the forms of guidance published by NICE and outlines the types for which there is a statutory responsibility for commissioners as well as the timescales within […]

Comparison of DPP-4 inhibitors (Gliptins)

There are currently five dipeptidyl peptidase-4 (DPP-4) inhibitors (or gliptins) available in the UK for the management of type 2 diabetes mellitus. There are a number of differences between the DPP-4 inhibitors in terms of licensing, interactions, renal impairment dose adjustment, hepatic impairment dose adjustment, and cost. This comparison table allows prescribers and other healthcare […]

Comparison of LAMA/LABA inhalers (update February 2021)

Comparison tables are produced for prescribers and medicines management teams. They are designed to assist in prescribing and decision-making within a specific therapeutic area. Long-acting muscarinic antagonists (LAMAs) and long-acting beta2 agonists (LABAs) are available in a variety of combination inhaler devices. This comparison table allows prescribers and other healthcare professionals to easily compare the […]